Gökben HIZLI SAYAR

Gökben HIZLI SAYAR


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2022 in BMC Psychology
Verified
Journal Article
Open access
PDF file
BÜBaşak Ünübol
Başak Ünübol
BÜBarış Önen Ünsalver
Barış Önen Ünsalver
HÜHüseyin ÜNÜBOL
Hüseyin ÜNÜBOL
GSGökben HIZLI SAYAR
Gökben HIZLI SAYAR
Background: The purpose of the present study was to comprehensively examine the measurement aspects, the prevalence, and the psychological correlates of problem shopping among a large-scale national sample of Turkish adults. Result: Participants (N = 24,380, 50% men, M age = 31.79 years, age range = 18–81 years) completed a questionnaire that comprised the Shopping Addiction Risk Questionnaire, the Brief Symptom Inventory, the Positive and Negative Affect Schedule, and the Experiences in Close Relationships-Revised. Results showed that 1.8% of the participants had probable shopping addiction. Being female, being younger, psychiatric distress, positive affect, negative affect, anxious attachment, and avoidant attachment were positive correlates of problem shopping. Conclusion: The results of this large sample size study suggest that shopping addiction is not a rare condition in Turkey. Further research is needed to understand different motives that underlie the problematic shopping behavior in the young and female population in comparison to older and male populations. Preventive programs or any interventions for people with PSB needs to address regulation difficulties and development of healthy strategies to cope with psychiatric distress.

20 November 2013 in Archives of Women's Mental Health
Verified
Journal Article
Closed access
PDF file
GSGökben HIZLI SAYAR
Gökben HIZLI SAYAR
EOEylem Ozten
Eylem Ozten
ETEvren Tufan
Evren Tufan
CCCem Cerit
Cem Cerit
GKGaye Kağan
Gaye Kağan
NTNevzat Tarhan
Nevzat Tarhan

1 June 2015 in Neuromodulation: Technology at the Neural Interface
Verified
Journal Article
Closed access
PDF file
GEGul Eryılmaz
Gul Eryılmaz
GSGökben HIZLI SAYAR
Gökben HIZLI SAYAR
EÖEylem Özten
Eylem Özten
IGIşıl Göğcegöz Gül
Işıl Göğcegöz Gül
ÖYÖzgür Yorbik
Özgür Yorbik
EBEda Bağcı
Eda Bağcı

1 April 2013 in Neuropsychiatric Disease and Treatment
Verified
Journal Article
Open access
PDF file
GSGökben HIZLI SAYAR
Gökben HIZLI SAYAR
EOEylem Ozten
Eylem Ozten
OTOguz Tan
Oguz Tan
NTNevzat Tarhan
Nevzat Tarhan
Purpose: The aim of the study reported here was to examine the safety and effectiveness of high-frequency repetitive transcranial magnetic stimulation (rTMS) in elderly patients with depression. Patients and methods: Sixty-five depressed elderly patients received rTMS over their left prefrontal cortex for 6 days per week, from Monday to Saturday, for 3 weeks. The rTMS intensity was set at 100% of the motor threshold and 25 Hz stimulation with a duration of 2 seconds and was delivered 20 times at 30-second intervals. A full course comprised an average of 1000 magnetic pulses. Depression was rated using the Hamilton Depression Rating Scale (HAMD) before and after treatment. Response was defined as a 50% reduction in HAMD score. Patients with HAMD scores < 8 were considered to be in remission. Results: The mean HAMD score for the study group decreased from 21.94 ± 5.12 before treatment to 11.28 ± 4.56 after rTMS (P < 0.001). Following the treatment period, 58.46% of the study group demonstrated significant mood improvement, as indexed by a reduction of more than 50% on the HAMD score. Nineteen of these 38 patients attained remission (HAMD score < 8), while 41.54% of all study patients achieved a partial response. None of the patients had a worsened HAMD score at the end of the treatment. Treatment was generally well tolerated and no serious adverse effects were reported. Conclusion: In this study, rTMS was found to be a safe, well-tolerated treatment, and a useful adjunctive treatment to medications in elderly treatment-resistant depressed patients. This study contributes to the existing evidence on the antidepressant effect of rTMS in the treatment of depression in patients over 60 years of age.

1 March 2020 in Clinical Neurophysiology
Verified
Journal Article
Closed access
TATuğçe Ballı Altuğlu
Tuğçe Ballı Altuğlu
BMBarış Metin
Barış Metin
ETEmine Elif Tülay
Emine Elif Tülay
OTOguz Tan
Oguz Tan
GSGökben HIZLI SAYAR
Gökben HIZLI SAYAR
NTNevzat Tarhan
Nevzat Tarhan

12 December 2013 in Annals of General Psychiatry
Verified
Journal Article
Open access
PDF file
GEGül Eryılmaz
Gül Eryılmaz
GSGökben HIZLI SAYAR
Gökben HIZLI SAYAR
EOEylem Ozten
Eylem Ozten
IGIşıl Gögcegöz Gül
Işıl Gögcegöz Gül
OKOğuz Karamustafalıoğlu
Oğuz Karamustafalıoğlu
Objective: Patients with schizophrenia often experience comorbid obsessive-compulsive symptoms. Within these patients, a significant subgroup developed secondary obsessive-compulsive symptoms during treatment with clozapine. Method: In this paper, we report on four cases in which adjunctive therapy with aripiprazole was tested to alleviate obsessive-compulsive symptoms in schizophrenia. Results: All four patients had a significant improvement in obsessive-compulsive symptoms. The combination of clozapine and aripiprazole was well tolerated. Conclusion: This case series demonstrates the clinical efficacy of aripiprazole adjunctive therapy with clozapine in schizophrenic patients with comorbid obsessive-compulsive symptoms. Larger-sampled and controlled studies are required in order to test and confirm these observations.